EK

Emily Kalin

Senior Financial Reporting Analyst at SAB Biotherapeutics

Emily Kalin started their work experience as an Audit Intern at Grant Thornton LLP in January 2017, and held the position until March 2017. In August 2017, they joined Lockton Companies as a Lockton, where they worked until July 2018. From October 2013 to August 2017, they worked at Johnnys Tavern as a Server/Bartender/Bar Manager. Emily then returned to Grant Thornton LLP in January 2019, this time as a Senior Associate Auditor, and stayed until May 2021. From June 2021 to July 2022, they worked at MidFirst Bank as an Internal Auditor II. Currently, Emily Kalin holds the position of Senior Financial Reporting Analyst at SAb Biotherapeutics since August 2022.

Emily Kalin obtained a Bachelor's degree in Accounting from the University of Missouri-Kansas City. Emily pursued their undergraduate education from 2014 to 2018.

Location

Oklahoma City, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


SAB Biotherapeutics

SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.


Industries

Employees

51-200

Links